Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ianny Brum, Reis"'
Autor:
João Carlos Cardoso Alonso, Bianca Ribeiro de Souza, Ianny Brum Reis, Gabriela Cardoso de Arruda Camargo, Gabriela de Oliveira, Maria Izabel de Barros Frazão Salmazo, Juliana Mattoso Gonçalves, José Ronaldo de Castro Roston, Paulo Henrique Ferreira Caria, André da Silva Santos, Leandro Luiz Lopes de Freitas, Athanase Billis, Nelson Durán, Wagner José Fávaro
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 24, p 17535 (2023)
This study assessed the safety and efficacy of OncoTherad® (MRB-CFI-1) nanoimmunotherapy for non-muscle invasive bladder cancer (NMIBC) patients unresponsive to Bacillus Calmette-Guérin (BCG) and explored its mechanisms of action in a bladder cance
Externí odkaz:
https://doaj.org/article/06fadeb0b99e4c6d8662c10ef891f929
Autor:
Ianny Brum Reis, Luiz Henrique Soares Tibo, Bianca Ribeiro de Souza, Nelson Durán, Wagner José Fávaro
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Autor:
Ianny Brum, Reis, Luiz Henrique Soares, Tibo, Bianca Ribeiro, de Souza, Nelson, Durán, Wagner José, Fávaro
Publikováno v:
Journal of cancer research and clinical oncology.
Bladder cancer is the second most common urinary tract cancer. Above 70% of the occurrence of bladder cancer is superficial (pTis, pTa, and pT1), non-muscle invasive tumor (NMIBC), and the incidence of invasive disease is occasional. Treatments for N
Autor:
Ianny Brum Reis, Patrick Vianna Garcia, Wagner José Fávaro, Nelson Durán, Eduardo Augusto Rabelo Socca, Petra Karla Bockelmann
Publikováno v:
Medical Oncology. 39
This work describes the effects of immunotherapy with Protein Aggregate Magnesium-Ammonium Phospholinoleate-Palmitoleate Anhydride (P-MAPA) in the treatment of non-muscle invasive bladder cancer (NMIBC) in an animal model. NMIBC was induced by treati
Autor:
Bianca Ribeiro de Souza, Gabriela Oliveira, Giovana Leme, Ianny Brum Reis, Felippe Augusto Tossini Cabral, Juliane Lima Baggio de Paula, Daniel Henrique da Silva Santos, Claudia Ronca Felizzola, Nelson Duran, Wagner José Fávaro
Publikováno v:
Journal of Clinical Oncology. 40:e17560-e17560
e17560 Background: Ovarian cancer (OC) ranks fifth among cancer deaths in women and remains the deadliest of all gynecological cancers. OncoTherad is a nanostructured complex developed by University of Campinas/Brazil, which exhibits immunomodulatory
Autor:
João Carlos Cardoso Alonso, Bianca Ribeiro de Souza, Giovana Leme, Ianny Brum Reis, Juliana Mattoso Gonçalves, Adriano Angelo Cintra, Leandro Luiz Lopes de Freitas, Fabio Gomes Pereira, Athanase Billis, Wagner José Fávaro
Publikováno v:
Journal of Clinical Oncology. 40:e16551-e16551
e16551 Background: This study detailed and characterized the mechanisms of action of OncoTherad nano-immunotherapy based on modulation of Toll-like Receptor 4 (TLR4) signaling pathway, CX3C chemokine receptor 1 (CX3CR1, a marker of T-cell differentia
Autor:
Gabriela Cardoso de Arruda Camargo, Queila Cristina Dias, Nelson Durán, Bianca Sasaki, Ianny Brum Reis, Wagner José Fávaro
Publikováno v:
Resumos do....
This study characterized the effects of the immunotherapy using the nanostructured complex OncoTherad, either associated or not to Platelet-Rich Plasm (PRP) on the non-muscle invasive bladder cancer (NMIBC) chemically induced in mice. The treatment w
Autor:
Queila Cristina Dias, Wagner José Fávaro, Bianca Ribeiro de Souza Sasaki, Gabriela Cardoso de Arruda Camargo, Nelson Durán, Ianny Brum Reis
Publikováno v:
Journal of Clinical Oncology. 39:461-461
461 Background: Effective intravesical therapies remain lacking for non-muscle invasive bladder cancer (NMIBC) when Bacillus Calmette-Guerin fails. OncoTherad is a nanostructured inorganic phosphate complex associated with glycosidic protein, develop
Autor:
Athanase Billis, Juliana Mattoso Gonçalves, Nelson Durán, Ianny Brum Reis, Bianca Ribeiro de Souza Sasaki, João Carlos Cardoso Alonso, Adriano Angelo Cintra, Wagner José Fávaro
Publikováno v:
Journal of Clinical Oncology. 38:e17048-e17048
e17048 Background: Standard treatment for high-grade non-muscle-invasive bladder cancer (HGNMIBC) is transurethral resection of the bladder tumor followed by intravesical Bacillus Calmette-Guérin (BCG) immunotherapy. Up to 40% of patients with HGNMI